The U.S. Food and Drug Administration approved the use of Sanofi and Regeneron's blockbuster drug Dupixent for patients with ...

A string of companies, including Sanofi India, Schaeffler India, CIE Automotive, and AMI Organics, will be in focus in the ...

On its way to generating sales of $14 billion in just its seventh full year on the market, Sanofi and Regeneron’s Dupixent ...

Sanofi India is divesting its insulin brand, Lantus, with Glenmark, Dr. Reddy's, and Emcure Pharma considering acquisition, ...

Regeneron Pharmaceuticals and Sanofi won U.S. Food and Drug Administration expanded approval of their blockbuster anti-inflammatory drug Dupixent for the inflammatory skin condition chronic ...

SAR442168 (tolebrutinib) is an orally bioavailable, brain-penetrant, selective, small-molecule inhibitor of Bruton's tyrosine ...

Investors need to pay attention to important dates of the Stock split and record date to remain eligible and make necessary ...

April 18 (Reuters) - The U.S. Food and Drug Administration approved the use of Sanofi (SASY.PA), opens new tab and Regeneron's (REGN.O), opens new tab blockbuster drug Dupixent for patients with a ...

Sanofi is continuing to splash the cash for autoimmune and immunology assets this spring by penning a new deal with little-known U.S. artificial intelligence research biotech Earendil Labs in a ...

Here is the complete list of companies whose shares will trade ex-date on April 17, 2025, along with their key corporate ...

Companies decide a cut-off date, termed as the record date to determine which shareholders will get the declared dividend, ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...